Flow Acquires Halo Neuroscience to Develop Brain Stimulation Technology to Treat Depression

Neurotech company Flow Neuroscience has acquired the rights to Halo Neuroscience’s brain stimulation technology in an effort to further its research goals of developing treatments for depression and other mental health disorders.

The company will use and further build upon Halo’s research on neuromodulation technology to enhance its current medically certified transcranial direct current stimulation (tDCS) headset for depression. The company will also collaborate with clinicians to leverage use of the new and improved headset in other areas, such as rehabilitation and motor impairment.